Blockbuster in the Pipeline: Hopefuls Bemdaneprocel and Elinzanetant
Legacy issues fade: Glyphosate lawsuits on the home stretch
Chart technology promises potential – 40 euros in sight
The long suffering of Bayer shareholders could soon come to an end: New medications, positive court rulings, and an exciting technical chart setup indicate a possible trend reversal – and could finally free the stock from its years-long sideways corridor.
Blockbuster in the Pipeline: Hopefuls Bemdaneprocel and Elinzanetant
Legacy issues fade: Glyphosate lawsuits on the home stretch
Chart technology promises potential – 40 euros in sight